The main cause of liver diseases worldwide is metabolic associated fatty liver disease (MAFLD) and affects nearly a quarter of the global population. Mohammed...
Previous trials have reported that weight loss interventions help in improving biomarkers of non-alcoholic fatty liver disease (NAFLD). Due to lack of data, it...
We have completed guidelines recommendation for “Exercise recommendations in individuals with valvular heart disease” in December month. Moving forward in this 2020 ESC guidelines,...
American Diabetes Association (ADA) leads in providing clinical recommendations as per the most current state of the field. In addition to many minor changes,...
B-blockers (BBs) are commonly used cardiovascular (CV) prevention medications in patients with end-stage kidney disease (ESKD) undergoing dialysis. Despite its widespread use, there is...
Diabetic ketoacidosis (DKA) is related to dehydration and can lead to acute kidney injury (AKI). No data is reporting the prevalence and associated risk...
